RT Journal Article SR Electronic T1 GABA-Based Evaluation of Neurologic Conditions: MR Spectroscopy JF American Journal of Neuroradiology JO Am. J. Neuroradiol. FD American Society of Neuroradiology SP 259 OP 265 DO 10.3174/ajnr.A2902 VO 34 IS 2 A1 Levy, L.M. A1 Degnan, A.J. YR 2013 UL http://www.ajnr.org/content/34/2/259.abstract AB SUMMARY: GABA serves as a major neurotransmitter of the brain and functions mainly to inhibit neural excitatory activity. Disruption of the GABAergic processes appears to occur in various neurologic and psychiatric conditions, including epilepsy, mood disorders, motor disorders such as focal dystonia and stiff-person syndrome, sleep disorders, neuroplasticity, and drug and alcohol dependence. These concentration differences may be ascertained by using MR spectroscopy to provide information on the concentration of different metabolites. This review briefly discusses advances in MR spectroscopy methods and explores the application of this technique to detect changes in GABA due to disease processes and medication-induced effects. AEDantiepileptic drugGABAγ-aminobutyric acidGABAARγ-amino butyric acid A receptorGABABRγ-amino butyric acid B receptorGABA-TGABA transaminaseGADglutamic acid decarboxylaseJ-PRESSa combined 2D point-resolved spectroscopy sequenceSSRIselective serotonin reuptake inhibitor